MedTrace Logo

Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer

NCT00210236 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 625

Last updated 2025-10-17

Study results available
· View outcomes & findings →

Summary

This randomized phase III trial is studying surgery and axillary lymph node dissection to evaluate if systematic Axillary Lymph Node Excision can be avoided in locoregional treatment for operable breast cancer smaller than 10 mm among menopausal women older than 50

Conditions

Interventions

PROCEDURE

Conventional surgery WITHOUT Axillary Lymph Node Excision

Tumorectomy or mastectomy, WITHOUT Axillary Lymph Node Excision

PROCEDURE

Conventional surgery WITH Axillary Lymph Node Excision

Sponsors & Collaborators

  • Institut Bergonié

    lead OTHER

Principal Investigators

  • Antoine AVRIL, MD · Institut Bergonié

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-09-30
Primary Completion
2005-12-31
Completion
2005-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00210236 on ClinicalTrials.gov